{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01539902",
      "OrgStudyIdInfo": {
        "OrgStudyId": "CT 11-03"
      },
      "Organization": {
        "OrgFullName": "CytoMed & Beike",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis",
      "OfficialTitle": "A Randomized, Double Blind, Parallel Group, Placebo Controlled Research of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis",
      "Acronym": "hUC-MSC-SLE"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2012",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "February 2012"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "March 2013",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "May 2013",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "February 22, 2012",
      "StudyFirstSubmitQCDate": "February 22, 2012",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "February 28, 2012",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "March 5, 2012",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "March 6, 2012",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "CytoMed & Beike",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "The efficacy measure of hUC-MSC in the treatment of proliferative lupus nephritis on remission of lupus nephritis (combined partial and complete remission) in terms of stabilization and improvement in renal function.",
      "DetailedDescription": "Inclusion criteria:\n\nMale or non-pregnant females age 16 to 65 years inclusive.\nWritten informed consent obtained from patient or parents/guardian.\nPatients with SLE fulfilling American Rheumatism Association criteria and SLEDAI score>8 or BILAG score A/B.\nPatients with newly diagnosed World Health Organization (WHO) Class III or IV Lupus Nephritis."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Lupus Nephritis"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "MSC for the treatment of Lupus Nephritis"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Double",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant",
              "Investigator"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "25",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Human Umbilical Cord derived MSCs",
            "ArmGroupType": "Experimental",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Human Umbilical Cord derived MSCs"
              ]
            }
          },
          {
            "ArmGroupLabel": "Cyclophosphamide",
            "ArmGroupType": "Placebo Comparator",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Cyclophosphamide"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Human Umbilical Cord derived MSCs",
            "InterventionDescription": "Human Umbilical Cord derived MSCs treatment for lupus nephritis via infusion",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Human Umbilical Cord derived MSCs"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Allogeneic stem cells derived from umbilical cord"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Cyclophosphamide",
            "InterventionDescription": "Cyclophosphamide based immunosuppressive agent for treatment for lupus nephritis",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Cyclophosphamide"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Immunosupressive agent"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Efficacy and Safety",
            "PrimaryOutcomeDescription": "The efficacy measure is remission of nephritis (combined partial and complete remission) at 6 months defined as\n\nStabilization or improvement in renal function and\nUrinary RBC of less than 10 per HPF and\nReduction of proteinuria to less than 3 g/day if baseline proteinuria was more than 3 g/day and at least a 50% reduction in proteinuria, or to less than 1 g/day if the baseline proteinuria was in the subnephrotic range.",
            "PrimaryOutcomeTimeFrame": "6 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nMale or non-pregnant females age 16 to 65 years inclusive.\nWritten informed consent obtained from patient or parents/guardian.\nPatients with SLE fulfilling American Rheumatism Association criteria and SLEDAI score>8 or BILAG score A/B.\nPatients with newly diagnosed World Health Organization (WHO) Class III or IV Lupus Nephritis\n\nExclusion Criteria:\n\nPatients with any of the following are not eligible for enrollment into the study:\n\nPregnant or nursing woman or women of childbearing potential except if post-menopausal, surgically sterile or using accepted method(s) of birth control or having negative pregnancy test.\nParticipation in any research in which the patient received an investigational product within 30 days preceding the screening phase of this study.\nThose persons directly involved in the conduct of the study.\nSerum creatinine more than 250 Âµmol/L.\nWhite blood cell (WBC) count of less than 3.5 X 109/L.\nActive peptic ulcer disease.\nActive systemic infection.\nHistory of alcohol or substance abuse.\nHistory of malignancy within previous 5 years.\nAny serious medical conditions or disability, which in the opinion of the investigator, would interfere with treatment or assessment or preclude completion of this study.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "16 Years",
      "MaximumAge": "65 Years",
      "StdAgeList": {
        "StdAge": [
          "Child",
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Second Affiliated Hospital & SLE Research Centre, Kunming Medical University, Kunming China",
            "LocationStatus": "Recruiting",
            "LocationCity": "Kunming",
            "LocationState": "Yunan",
            "LocationZip": "650000",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "PeiLian Zhang, Dr",
                  "LocationContactRole": "Contact",
                  "LocationContactEMail": "mzczpl1968@163.com"
                },
                {
                  "LocationContactName": "DanQi Deng, Professor",
                  "LocationContactRole": "Principal Investigator"
                },
                {
                  "LocationContactName": "PeiLian Zhang, Dr",
                  "LocationContactRole": "Sub-Investigator"
                }
              ]
            }
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "28478399",
            "ReferenceType": "derived",
            "ReferenceCitation": "Deng D, Zhang P, Guo Y, Lim TO. A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis. Ann Rheum Dis. 2017 Aug;76(8):1436-1439. doi: 10.1136/annrheumdis-2017-211073. Epub 2017 May 6."
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000009393",
            "ConditionMeshTerm": "Nephritis"
          },
          {
            "ConditionMeshId": "D000008181",
            "ConditionMeshTerm": "Lupus Nephritis"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000007674",
            "ConditionAncestorTerm": "Kidney Diseases"
          },
          {
            "ConditionAncestorId": "D000014570",
            "ConditionAncestorTerm": "Urologic Diseases"
          },
          {
            "ConditionAncestorId": "D000005921",
            "ConditionAncestorTerm": "Glomerulonephritis"
          },
          {
            "ConditionAncestorId": "D000008180",
            "ConditionAncestorTerm": "Lupus Erythematosus, Systemic"
          },
          {
            "ConditionAncestorId": "D000003240",
            "ConditionAncestorTerm": "Connective Tissue Diseases"
          },
          {
            "ConditionAncestorId": "D000001327",
            "ConditionAncestorTerm": "Autoimmune Diseases"
          },
          {
            "ConditionAncestorId": "D000007154",
            "ConditionAncestorTerm": "Immune System Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M11490",
            "ConditionBrowseLeafName": "Nephritis",
            "ConditionBrowseLeafAsFound": "Nephritis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M10330",
            "ConditionBrowseLeafName": "Lupus Nephritis",
            "ConditionBrowseLeafAsFound": "Lupus Nephritis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9850",
            "ConditionBrowseLeafName": "Kidney Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16471",
            "ConditionBrowseLeafName": "Urologic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8183",
            "ConditionBrowseLeafName": "Glomerulonephritis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10329",
            "ConditionBrowseLeafName": "Lupus Erythematosus, Systemic",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5616",
            "ConditionBrowseLeafName": "Connective Tissue Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M3781",
            "ConditionBrowseLeafName": "Autoimmune Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9352",
            "ConditionBrowseLeafName": "Immune System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T3523",
            "ConditionBrowseLeafName": "Lupus Nephritis",
            "ConditionBrowseLeafAsFound": "Lupus Nephritis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T2525",
            "ConditionBrowseLeafName": "Glomerulonephritis",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BXS",
            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC20",
            "ConditionBrowseBranchName": "Immune System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionMeshList": {
        "InterventionMesh": [
          {
            "InterventionMeshId": "D000003520",
            "InterventionMeshTerm": "Cyclophosphamide"
          }
        ]
      },
      "InterventionAncestorList": {
        "InterventionAncestor": [
          {
            "InterventionAncestorId": "D000007166",
            "InterventionAncestorTerm": "Immunosuppressive Agents"
          },
          {
            "InterventionAncestorId": "D000007155",
            "InterventionAncestorTerm": "Immunologic Factors"
          },
          {
            "InterventionAncestorId": "D000045505",
            "InterventionAncestorTerm": "Physiological Effects of Drugs"
          },
          {
            "InterventionAncestorId": "D000018501",
            "InterventionAncestorTerm": "Antirheumatic Agents"
          },
          {
            "InterventionAncestorId": "D000018906",
            "InterventionAncestorTerm": "Antineoplastic Agents, Alkylating"
          },
          {
            "InterventionAncestorId": "D000000477",
            "InterventionAncestorTerm": "Alkylating Agents"
          },
          {
            "InterventionAncestorId": "D000045504",
            "InterventionAncestorTerm": "Molecular Mechanisms of Pharmacological Action"
          },
          {
            "InterventionAncestorId": "D000000970",
            "InterventionAncestorTerm": "Antineoplastic Agents"
          },
          {
            "InterventionAncestorId": "D000019653",
            "InterventionAncestorTerm": "Myeloablative Agonists"
          }
        ]
      },
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M5879",
            "InterventionBrowseLeafName": "Cyclophosphamide",
            "InterventionBrowseLeafAsFound": "Months",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M9364",
            "InterventionBrowseLeafName": "Immunosuppressive Agents",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M9353",
            "InterventionBrowseLeafName": "Immunologic Factors",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M19757",
            "InterventionBrowseLeafName": "Antirheumatic Agents",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M20095",
            "InterventionBrowseLeafName": "Antineoplastic Agents, Alkylating",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M2972",
            "InterventionBrowseLeafName": "Alkylating Agents",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "ANeo",
            "InterventionBrowseBranchName": "Antineoplastic Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "ARhu",
            "InterventionBrowseBranchName": "Antirheumatic Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}